84 related articles for article (PubMed ID: 25409899)
1. Optimal dose-setting study of curcumin for improvement of left ventricular systolic function after myocardial infarction in rats.
Sunagawa Y; Sono S; Katanasaka Y; Funamoto M; Hirano S; Miyazaki Y; Hojo Y; Suzuki H; Morimoto E; Marui A; Sakata R; Ueno M; Kakeya H; Wada H; Hasegawa K; Morimoto T
J Pharmacol Sci; 2014; 126(4):329-36. PubMed ID: 25409899
[TBL] [Abstract][Full Text] [Related]
2. A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats.
Sunagawa Y; Morimoto T; Wada H; Takaya T; Katanasaka Y; Kawamura T; Yanagi S; Marui A; Sakata R; Shimatsu A; Kimura T; Kakeya H; Fujita M; Hasegawa K
Circ J; 2011; 75(9):2151-9. PubMed ID: 21737953
[TBL] [Abstract][Full Text] [Related]
3. A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats.
Sunagawa Y; Wada H; Suzuki H; Sasaki H; Imaizumi A; Fukuda H; Hashimoto T; Katanasaka Y; Shimatsu A; Kimura T; Kakeya H; Fujita M; Hasegawa K; Morimoto T
Biol Pharm Bull; 2012; 35(2):139-44. PubMed ID: 22293342
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
[TBL] [Abstract][Full Text] [Related]
5. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats.
Morimoto T; Sunagawa Y; Kawamura T; Takaya T; Wada H; Nagasawa A; Komeda M; Fujita M; Shimatsu A; Kita T; Hasegawa K
J Clin Invest; 2008 Mar; 118(3):868-78. PubMed ID: 18292809
[TBL] [Abstract][Full Text] [Related]
6. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of myocardial systolic function of heart failure induced by myocardial infarction in rats with strain and strain rate imagine].
Zhu W; Tang S; Duan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):590-7. PubMed ID: 20622332
[TBL] [Abstract][Full Text] [Related]
8. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
Tao ZW; Huang YW; Xia Q; Xu QW
Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
11. The effects of poloxamer-188 on left ventricular function in chronic heart failure after myocardial infarction.
Juneman EB; Saleh L; Lancaster JJ; Thai HM; Markham B; Goldman S
J Cardiovasc Pharmacol; 2012 Sep; 60(3):293-8. PubMed ID: 22653419
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K
Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304
[TBL] [Abstract][Full Text] [Related]
13. Swimming exercise training prior to acute myocardial infarction attenuates left ventricular remodeling and improves left ventricular function in rats.
Dayan A; Feinberg MS; Holbova R; Deshet N; Scheinowitz M
Ann Clin Lab Sci; 2005; 35(1):73-8. PubMed ID: 15830712
[TBL] [Abstract][Full Text] [Related]
14. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
15. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ
J Am Coll Cardiol; 2007 Feb; 49(7):811-21. PubMed ID: 17306712
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
Lal A; Veinot JP; Ganten D; Leenen FH
J Mol Cell Cardiol; 2005 Sep; 39(3):521-9. PubMed ID: 15950985
[TBL] [Abstract][Full Text] [Related]
19. Recombinant proteins secreted from tissue-engineered bioartificial muscle improve cardiac dysfunction and suppress cardiomyocyte apoptosis in rats with heart failure.
Rong SL; Wang YJ; Wang XL; Lu YX; Wu Y; Liu QY; Mi SH; Xu YL
Chin Med J (Engl); 2010 Dec; 123(24):3626-2633. PubMed ID: 22166642
[TBL] [Abstract][Full Text] [Related]
20. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
